Oncolytics Biotech
Biotechnology company developing REOLYSIN, an intravenously delivered oncolytic reovirus immunotherapy treatment for multiple cancer types through clinical trials and partnerships.
About
What Oncolytics Biotech is
Biotechnology company developing REOLYSIN, an intravenously delivered oncolytic reovirus immunotherapy treatment for multiple cancer types through clinical trials and partnerships.
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
EnterpriseHealthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://oncolyticsbiotech.com |
| Status coverage | Public status page |
| Founded | 1998 |
| Headquarters | Calgary, Alberta, Canada |
| Categories | Enterprise, Healthcare |
Loading offerings...